There is a growing narrative that if we can effectively reduce excess weight, we can “solve” metabolic disease. While weight ...

Non-profit research organisation Biohub has released what it claims is an AI-powered "world model" of protein biology that ...

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax Technologies has aspirations to knock off its crown. The Emeryville, California-based biotech ...

After its advisory committee voted against AstraZeneca's camizestrant as a treatment for breast cancer in April, the FDA has ...

Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with ...

A $140 million fund has been launched by Coefficient Giving, a health-focused philanthropic organisation, to fund R&D into ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

Sobi's $1.5 billion takeover of Arthrosi at the end of 2025 has started to pay off, with a positive phase 3 trial for gout ...

Around seven years after exiting the infectious disease category, Eli Lilly is back – thanks to a trio of acquisitions worth more than $3.8 billion. At a stroke, the deals to acquire Curevo, LimmaTech ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Kris Kaneta, chief product officer at Norstella, which is helping life sciences companies speed up development with instant ...

Inizio, the leading global commercialization partner to the health and life sciences industry, today announced the launch of ...

Digital medicine specialist Newel Health has formed an alliance with packaging group Gerresheimer to help pharma companies ...